Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries.
about
Low-intensity shock wave therapy and its application to erectile dysfunction.Research in pharmacotherapy for erectile dysfunctionA New Strategy for Deleting Animal drugs from Traditional Chinese Medicines based on Modified Yimusake Formula.Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?Inhibition of Ninjurin 1 restores erectile function through dual angiogenic and neurotrophic effects in the diabetic mouse.Reversion of penile fibrosis: Current information and a new horizon.Nitric oxide-induced vasorelaxation in response to PnTx2-6 toxin from Phoneutria nigriventer spider in rat cavernosal tissue.Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function.Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation.Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction.Stem Cell Therapy for Diabetic Erectile Dysfunction in Rats: A Meta-Analysis.Analysis of erectile responses to BAY 41-8543 and muscarinic receptor stimulation in the ratCa2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension.Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitusPharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors.Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway.Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant Is Glycemic Control?Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa.Constitutive NOS uncoupling and NADPH oxidase upregulation in the penis of type 2 diabetic men with erectile dysfunction.Chronic treatment with taurine ameliorates diabetes-induced dysfunction of nitric oxide-mediated neurogenic and endothelium-dependent corpus cavernosum relaxation in rats.Panax notoginseng saponins improve the erectile dysfunction in diabetic rats by protecting the endothelial function of the penile corpus cavernosum.Penile neurovascular structure revisited: immunohistochemical studies with three-dimensional reconstruction.Do penile haemodynamics change in the presence of hydrogen sulphide (H2 S) donor in metabolic syndrome-induced erectile dysfunction?Lipoxin A4 improves erectile dysfunction in rats with type I diabetes by inhibiting oxidative stress and corporal fibrosis.Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction.Intracavernous delivery of clonal mesenchymal stem cells rescues erectile function in the streptozotocin-induced diabetic mouse.Effect of a novel BKCa opener on BKCa currents and contractility of the rabbit corpus cavernosum.Antifibrogenic role of valproic acid in streptozotocin induced diabetic rat penis.Comparison of sildenafil with strontium fructose diphosphate in improving erectile dysfunction against upregulated cavernosal NADPH oxidase, protein kinase Cε, and endothelin system in diabetic rats.
P2860
Q30444179-FD8FF5EB-F146-4C1C-B53E-340C0478BCF5Q33650796-B2053226-74FA-4444-86B1-A2D475801178Q33685427-A375F19D-5DDB-4169-928F-9108E7336CE9Q33812742-E5AAC5E6-523C-4946-8042-F2371A6C2763Q33854121-8BAAD627-7107-48AF-9E9B-6956FD4F35C3Q34502071-976F5EA7-53CC-402E-BF27-B2FB5B0CDE6FQ34622646-43C4EA0D-31F4-43C2-A15B-323D4F1AB977Q34973749-02AD6A45-DDE1-4E88-AB8B-1385F4FB618BQ35050926-C44BBE7B-4E37-412B-A084-C6707F7A5E8CQ35111461-188CD6CD-66B4-4F10-84F7-48EB40778D63Q35802924-D817175E-162D-424C-94D5-35A71C79F2E0Q35998331-D7614E95-5F27-450A-8F1F-47E93B5366F8Q36674593-D6469AB3-18F6-4FDF-BF23-D56D5223D7B4Q36836444-C8190146-64BF-4E79-BE64-111E69AC594BQ38126803-95ED33FC-B324-418E-A379-C0C20CA3D116Q38466768-96DF543E-7E1C-407F-BD80-71D4CCC16E98Q38815890-BC75C8DF-0B6A-4EA4-91CE-44BA439B57AEQ39195242-42CF28D8-5F3C-40B2-9794-36D8D24C8EB4Q40378041-DE784382-74AA-4701-BF06-5A8DDB8D7AC9Q41873056-4208E67B-DF80-4D74-8DD4-036F2996593BQ46433965-94E882D4-DDA3-4800-93A3-7056283326C6Q46645295-804D0AE9-3A15-4521-8272-DC39B88CBDDEQ46721558-6FA89DA3-4894-4186-8F07-FF5D7179E640Q47819112-734652D3-25B4-444E-97EB-5EA9541CCE53Q48355895-3663C35B-23DF-4AC1-9D67-8D2D2E37D51FQ50125343-07F62CC9-C754-4504-B2D1-C66E6882861DQ50982493-7E5DC87E-C22E-4A15-982A-6534DAF525EAQ52892269-0D71F5D3-64C4-49D5-9BBA-393D86CB68F0Q53246913-F78A0B3A-DA4F-45FF-B91E-B7140C0B554FQ53378646-D4E4BF43-4BE0-4171-BB24-64AE3D3E940AQ54330771-61F01321-EF5A-4435-B3BD-8E4B2E4E04D8
P2860
Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Diabetes exacerbates the funct ...... avernosum and penile arteries.
@en
Diabetes exacerbates the funct ...... avernosum and penile arteries.
@nl
type
label
Diabetes exacerbates the funct ...... avernosum and penile arteries.
@en
Diabetes exacerbates the funct ...... avernosum and penile arteries.
@nl
prefLabel
Diabetes exacerbates the funct ...... avernosum and penile arteries.
@en
Diabetes exacerbates the funct ...... avernosum and penile arteries.
@nl
P2093
P1476
Diabetes exacerbates the funct ...... avernosum and penile arteries.
@en
P2093
Antonio Allona
Argentina Fernández
Francisco Rolo
Iñigo Sáenz de Tejada
Javier Angulo
José M La Fuente
Pedro Cuevas
Rocío González-Corrochano
P304
P356
10.1111/J.1743-6109.2009.01587.X
P433
P577
2009-11-12T00:00:00Z